The dissemination of medical information online in real time has forever changed the relationship between today's physician and patient. The idea that accurate and meaningful information can only flow in one direction is now extinct.
How can physicians take advantage of social media (SM)-in the form of online forums, microblogs (eg, Twitter), video, blogs, social networks, and podcasts1-as an opportunity to engage with patients and improve their care?
Here to discuss is Dr Farris Timimi, Assistant Professor of Medicine at the Mayo Clinic and Medical Director of the Mayo Clinic Center for Social Media, in Rochester, Minn. Dr Timimi can be found on Twitter at @FarrisTimimi.
Social Media in Medicine
Take home points
• SM is an opportunity for physicians to change community outcomes and improve patient care
• Because the 3 most common online activities include internet search, e-mail, and searching for health care information, physicians are obligated to put reliable health care information in the path of the patient
• SM is a logical extension of clinical practice, research, and education
• Content curation and content creation have “profound value” to patients and caregiver, so it is incumbent upon physicians to develop and review their organizational SM policy guide1
Reference
1. Timimi FK. Medicine, morality and health care. BMC Med. 2012;10:83.
Social Media and Medicine: A Winning Combination
Dr Farris Timimi, Assistant Professor of Medicine at the Mayo Clinic and Medical Director of the Mayo Clinic Center for Social Media, discusses the potential of social media to change the landscape of clinical practice.
The dissemination of medical information online in real time has forever changed the relationship between today's physician and patient. The idea that accurate and meaningful information can only flow in one direction is now extinct.
How can physicians take advantage of social media (SM)-in the form of online forums, microblogs (eg, Twitter), video, blogs, social networks, and podcasts1-as an opportunity to engage with patients and improve their care?
Here to discuss is Dr Farris Timimi, Assistant Professor of Medicine at the Mayo Clinic and Medical Director of the Mayo Clinic Center for Social Media, in Rochester, Minn. Dr Timimi can be found on Twitter at @FarrisTimimi.
Social Media in Medicine
Take home points
• SM is an opportunity for physicians to change community outcomes and improve patient care
• Because the 3 most common online activities include internet search, e-mail, and searching for health care information, physicians are obligated to put reliable health care information in the path of the patient
• SM is a logical extension of clinical practice, research, and education
• Content curation and content creation have “profound value” to patients and caregiver, so it is incumbent upon physicians to develop and review their organizational SM policy guide1
Reference
1. Timimi FK. Medicine, morality and health care. BMC Med. 2012;10:83.
Centralizing evidence to boost efficiency across life sciences functions
May 28th 2025The life sciences industry is growing as medtech, biopharma, and investors all face an era of unprecedented innovation and potential. However, firms are also preparing as much as possible for unexpected business challenges and the likelihood of volatility. In an industry that must balance profitability with product efficacy, many life sciences firms are working with new efficiencies to bolster research. In this whitepaper from Wolters Kluwer, you will learn how centralized, unified, and coordinated resources can help organizations overcome fragmented processes and miscommunications, leading to enhanced problem-solving and collaboration, as well as improved outcomes.
The Weekly Dose: How Medicaid Policies Impact Postpartum Depression Care
At ACOG 2025, Elizabeth Mollard, PhD, discussed her research on Medicaid PPD screening and coverage policies on PPD diagnosis.
ASCO 2025: GLP-1 Receptor Agonists Linked to Modest Reduction in Obesity-Related Cancer Risk
GLP-1 receptor agonists showed promise in lowering obesity-related cancer risks in adults with type 2 diabetes, particularly colorectal cancer.
Weekly Dose: A Roundup of Top Stories for Primary Care Physicians
PODCAST: Listen to our first episode for new research on bacterial vaginosis, a new treatment option for chronic urticaria, and more.
Novel Aryl Hydrocarbon Receptor Agonist Vtama® (tapinarof) Cream 1% for Treatment of Atopic Dermatitis
May 28th 2025IV Ibuprofen Cuts Postop Opioid Use by 23% in Older Adults, Study Finds
The opioid-sparing IVIB pain management strategy in adults aged 60 and older was effective in the immediate post-surgical period and associated with limited AEs.
Centralizing evidence to boost efficiency across life sciences functions
May 28th 2025The life sciences industry is growing as medtech, biopharma, and investors all face an era of unprecedented innovation and potential. However, firms are also preparing as much as possible for unexpected business challenges and the likelihood of volatility. In an industry that must balance profitability with product efficacy, many life sciences firms are working with new efficiencies to bolster research. In this whitepaper from Wolters Kluwer, you will learn how centralized, unified, and coordinated resources can help organizations overcome fragmented processes and miscommunications, leading to enhanced problem-solving and collaboration, as well as improved outcomes.
The Weekly Dose: How Medicaid Policies Impact Postpartum Depression Care
At ACOG 2025, Elizabeth Mollard, PhD, discussed her research on Medicaid PPD screening and coverage policies on PPD diagnosis.
ASCO 2025: GLP-1 Receptor Agonists Linked to Modest Reduction in Obesity-Related Cancer Risk
GLP-1 receptor agonists showed promise in lowering obesity-related cancer risks in adults with type 2 diabetes, particularly colorectal cancer.
Weekly Dose: A Roundup of Top Stories for Primary Care Physicians
PODCAST: Listen to our first episode for new research on bacterial vaginosis, a new treatment option for chronic urticaria, and more.
Novel Aryl Hydrocarbon Receptor Agonist Vtama® (tapinarof) Cream 1% for Treatment of Atopic Dermatitis
May 28th 2025IV Ibuprofen Cuts Postop Opioid Use by 23% in Older Adults, Study Finds
The opioid-sparing IVIB pain management strategy in adults aged 60 and older was effective in the immediate post-surgical period and associated with limited AEs.